US Patent 12090125 Combination therapy
Patent 12090125 was granted and assigned to Novartis on September, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
July 26, 2021
0
Date of Patent
September 17, 2024
0
Patent Applicant
Patent Application Number
17385008
0
Patent Citations
Patent Inventor Names
James E. Foley
0
Stefano Del Prato
0
Michael Stumvoll
0
Päivi M. Paldánius
0
Wolfgang Kothny
0
David R. Matthews
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
CPC Code
Find more entities like US Patent 12090125 Combination therapy
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
